GSK Australia
- Invasive meningococcal disease (IMD) is rare and most people survive.1 However, even with appropriate medical care, up to 1 in 10 patients who contract IMD may die, typically within 24-48 hours from first symptoms.2,3 Up to 1 in 5 survivors may develop long-term disabilities.3
- GSK research shows most (72%) Australian parents are aware that IMD is a serious infection, but only 19% are aware that IMD can be caused by multiple bacterial strains.4
- Invasive meningococcal disease cases are expected to peak in winter and early spring.6 As of September, 88* cases have been recorded nationally this year.5
/Public Release.
